Search results: Medicine

No videos found

Sjöbergpriset 2021
Sjöbergpriset 2021 tilldelas Benjamin L. Ebert, Harvard University och Dana-Farber Cancer Institute, Boston, MA, USA. Han tilldelas priset ”för sin upptäckt av verkningsmekanismen för lenalidomid vid behandling av blodsjukdomar” Video News Release: Sjöbergpriset 2021, 2021-02-15.
Sjöberg Prize 2021
The Sjöberg Prize 2021 is awarded to Benjamin L. Ebert, Harvard University and Dana-Farber Cancer Institute, Boston, MA, USA. He is awarded the Sjöberg Prize “for his discovery of the mode of action of lenalidomide in the treatment of haematological disorders”. Video News Release: Sjöberg Prize 2021, 2021-02-15.
The Crafoord Prize in Polyarthritis 2021
Daniel L. Kastner, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA, is awarded the Crafoord Prize in Polyarthritis 2021 “for establishing the concept of autoinflammatory diseases”. Video News Release, The Crafoord Prize in Polyarthritis 2021, 2021-02-01.
Sjöberg Prize 2020
The Sjöberg Prize 2020 is awarded to Michael N. Hall, Biozentrum, University of Basel, Switzerland and David M. Sabatini, Massachusetts Institute of Technology (MIT) and Whitehead Institute, Cambridge, USA ”for their discovery of mTOR and its role in the control of cell metabolism and growth.” Video News Release: Sjöberg Prize 2020, 2020-02-04.
Molecular Diversity of Human Breast Cancers: Biologic and Therapeutic Implications
Sjöberg Prize Laureate Dennis J. Slamon, University of California, Los Angeles, USA. From: Sjöberg Prize Lectures, 2019-03-29.
Imatinib as a Paradigm of Targeted Cancer Therapies
Sjöberg Prize Laureate Brian J. Druker, Oregon Health & Science University, Portland, USA. From: Sjöberg Prize Lectures, 2019-03-29.
Sjöberg Prize 2019
The Sjöberg Prize 2019 is awarded to Dennis J. Slamon, University of California, Los Angeles and Brian J. Druker, Oregon Health & Science University, Portland, USA “for their groundbreaking contributions to the clinical development of targeted therapy directed against genetic aberrations in cancer.”
Lessons for the 21st century from medical pioneers in the “mists of time”?
Iain McInnes, Institute of Infection, Immunity and Inflammation, University of Glasgow, United Kingdom. Welcome remarks by Olle Kämpe, the Crafoord Prize Committee for Polyarthritis and Anders Bengtsson, Lund University. From: Crafoord Academy Lecture 2018: Lessons for the 21st century from medical pioneers in the “mists of time”?, 2018-11-27.
From liver cancer to acute promyelocytic leukemia, and beyond
Sjöberg Prize Laureate Anne Dejean, Institut Pasteur and Inserm, Paris, France. From: Sjöberg Prize Lectures, 2018-04-12.
Deciphering APL pathogenesis through therapy response
Sjöberg Prize Laureate Hugues de Thé, Collège de France, Paris, France. From: Sjöberg Prize Lectures, 2018-04-12.
Interview with Anne Dejean
Interview with Sjöberg Prize Laureate 2018: Anne Dejean, Institut Pasteur and Inserm, Paris, France. From: Interview with The Sjöberg Prize Laureates 2018, 2018-04-12.
Interview with Hugues de Thé
Interview with Sjöberg Prize Laureate 2018: Hugues de Thé, Collège de France, Paris, France. From: Interview with The Sjöberg Prize Laureates 2018, 2018-04-12.
Interview with Zhu Chen
Interview with Sjöberg Prize Laureate 2018: Zhu Chen, Shanghai Jiao Tong University, China. From: Interview with The Sjöberg Prize Laureates 2018, 2018-04-12.
When killing your own is necessary
Pristagaren Yenan Bryceson, doktor vid Karolinska Institutet. Från offentliggörandet av Göran Gustafssonprisen 2018, 2018-04-13.
Precision medicine: facilitating cancer treatment decisions and drug development
Olli Kallioniemi, dept. Oncology/Pathology, Karolinska Institutet and Science for Life Laboratory, Stockholm. From: Open Academy Lecture, 2017-06-14.
Tyrosine Phosphorylation - From Discovery to Drug Development and Beyond
Sjöberg Prize Laureate 2017: Tony Hunter, Salk Institute for Biological Studies. Introduction by: Bengt Westermark, The Sjöberg Prize Committee. From: The Sjöberg Prize Lectures 2017, 2017-03-30.
Immune Checkpoint Blockade in Cancer Therapy: Prospects for Cures
Sjöberg Prize Laureate 2017: James P. Allison, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Introduction by: Klas Kärre, The Sjöberg Prize Committee. From: The Sjöberg Prize Lectures 2017, 2017-03-30.